⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PYPD News
PolyPid Ltd. Ordinary Shares
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
globenewswire.com
PYPD
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
globenewswire.com
PYPD
PolyPid Announces Participation in Upcoming Fall Investor Conferences
globenewswire.com
PYPD
PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results
globenewswire.com
PYPD
PolyPid to Report Second Quarter 2026 Financial Results and Operational Highlights on August 12, 2026
globenewswire.com
PYPD
PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
globenewswire.com
PYPD
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
globenewswire.com
PYPD
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
globenewswire.com
PYPD
PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀
globenewswire.com
PYPD
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
globenewswire.com
PYPD